Enveric Biosciences, Inc. (ENVB) IPO - S-1 Filing, Stock & Insider Activity
Enveric Biosciences, Inc. IPO - Status & S-1 Filing
- Ticker: ENVB
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-02-10
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0000890821 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Enveric Biosciences, Inc. (ENVB) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-03. 4 Form 8-K material event filings were reported by ENVB in the last 90 days. InsiderAlpha tracks every ENVB SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. trades under the ticker ENVB. InsiderAlpha tracks 23 primary SEC Form 4 filings from 8 reporting insiders for ENVB since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0000890821 |
|---|
90-Day SEC Filing Activity
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-06-03 |
Recent ENVB Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joseph Edward Tucker | Chief Executive Officer | A - Grant or award | 201.1K | $0.00 | - | SEC | |
| Frank Pasqualone | Insider | A - Grant or award | 18.5K | $0.00 | - | SEC | |
| Michael D. Webb | Insider | A - Grant or award | 18.5K | $0.00 | - | SEC | |
| Marcus Schabacker | Insider | A - Grant or award | 18.5K | $0.00 | - | SEC | |
| George A. Kegler | Insider | A - Grant or award | 18.5K | $0.00 | - | SEC | |
| Sheila Dewitt | Insider | A - Grant or award | 18.5K | $0.00 | - | SEC | |
| Peter J. Facchini | Chief Innovation Officer | A - Grant or award | 25.0K | $0.00 | - | SEC | |
| Kevin Michael Coveney | Chief Financial Officer | A - Grant or award | 133.3K | $0.00 | - | SEC | |
| Frank Pasqualone | Insider | A - Grant or award | 7.6K | $0.00 | - | SEC | |
| Sheila Dewitt | Insider | A - Grant or award | 7.6K | $0.00 | - | SEC | |
| Michael D. Webb | Insider | A - Grant or award | 7.6K | $0.00 | - | SEC | |
| Kevin Michael Coveney | Chief Financial Officer | A - Grant or award | 40.2K | $0.00 | - | SEC | |
| Joseph Edward Tucker | Chief Executive Officer | A - Grant or award | 60.3K | $0.00 | - | SEC | |
| Marcus Schabacker | Insider | A - Grant or award | 7.6K | $0.00 | - | SEC | |
| George A. Kegler | Insider | A - Grant or award | 7.6K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Enveric Biosciences, Inc. (ENVB). Updated in real time as new filings are submitted to the SEC.
Most-Active ENVB Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Michael D. Webb | 1 | - |
| Frank Pasqualone | 1 | - |
| Marcus Schabacker | 1 | - |
| George A. Kegler | 1 | - |
| Joseph Edward Tucker | 1 | - |
Recent ENVB Form 8-K Material Events
- - Item 8.01, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
- - Item 5.02, 5.07, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 1.01, 3.02, 8.01, 9.01 · Financing · mixed [SEC]
Enveric Biosciences completed a private placement of common stock, pre-funded warrants, and Series I and J warrants with institutional investors. The offering includes 98,000 shares of common stock, pre-funded warrants for 2.1M shares, and warrants for 4.4M shares at $2.00 exerci
Recent Insider Filings
- - Kevin Michael Coveney (Chief Financial Officer)
- - Joseph Edward Tucker (Chief Executive Officer)
- - Frank Pasqualone (Insider)
- - Michael D. Webb (Insider)
- - Marcus Schabacker (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ENVB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ENVB Insider Trading - FAQ
- What is the latest insider trade for ENVB?
- Enveric Biosciences, Inc. (ENVB) had 8 insider filings in the last 90 days, with the most recent on 2026-06-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ENVB stock?
- 0 insider purchases of ENVB were filed in the last 90 days.
- How many insiders are selling ENVB stock?
- 0 insider sales of ENVB were filed in the last 90 days.
- Where can I see ENVB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ENVB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $EOHC Edison Oncology Holding Corp
- $EPWKF EPWK Holdings Ltd.
- $EQPT EquipmentShare.com Inc
- $EROC ERock, Inc.
- $EROK EagleRock Land, LLC
- $ESLA Estrella Immunopharma, Inc.
- $ETHB iShares Staked Ethereum Trust ETF
- $ETSS Energy Transition Special Opportunities
- $EUPX EUPEC International Group Ltd
- $EVAX Evaxion A/S
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ENVB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.